Sponsor: MolecularMDIn this eBook learn how MolecularMD is harnessing the company's unique capabilities to address diagnostic needs within immuno-oncology.
Sponsor: IlluminaIn this Keynote Webinar, sponsored by Illumina, two leading researchers will show how genomic technologies are tackling the COVID-19 pandemic—Alex Greninger, MD, PhD, (University of Washington School of Medicine) and Darrell Dinwiddie PhD, (University of New Mexico Health Sciences Center).
Sponsor: MolecularMDDownload this eBook to learn how MolecularMD helped usher in a new era of CML treatment now prescribed by progressive clinicians.
Sponsor: IlluminaIn this inaugural Clinical OMICs Keynote webinar, we are proud to host two renowned leaders in the field of genomic medicine, Drs Stephen Kingsmore and Robert Green, who will discuss their pioneering work in the field of newborn genome sequencing and analysis.
In this eBook, sponsored by Qiagen, we explore the opportunities and challenges of precision oncology and how molecular profiling is fundamental not only to inform on tumor diagnosis and prognosis, but also to drive therapeutic decisions in routine clinical care.
Sponsor: ThermoFisher ScientificLarge cohort studies are essential to the discovery of protein biomarkers, and their validation is indispensable to clinical utility.
Detection of Ovarian Cancer Recurrence: Quality Control Routines using an Integrated Proteomics Approach
Sponsor: ThermoFisher ScientificThe webinar will focus on some of the current challenges facing researchers looking to improve biomarker discovery for ovarian cancer.
Sponsor: Qiagen REGISTER NOW Broadcast Date: September 12, 2019 Time: 8:00 am PT, 11:00 am ET, 17:00 CET BRCA1/BRCA2 genes represent the best examples for our current understanding of...
Sponsor: TakedaTakeda has taken great strides in incorporating a patient-centric approach to drug development through the use of minimally invasive and less frequent testing procedures while maintaining the power and rigor of the clinical trial.
Sponsor: QiagenIn this webinar, we will describe Quest’s LeukoVantage assay, an NGS test designed specifically for detecting clinically relevant variants in myeloid malignancies, and its partnership with N-of-One, a QIAGEN company, for expert interpretation.